A meta-analysis of the effects of treatment on left ventricular mass in essential hypertension.
By A. Klingbeil, Markus P. Schneider, P. Martus, F. Messerli, R. Schmieder. American Journal of Medicine, 2003
737 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism
View Paper: https://www.semanticscholar.org/paper/47b025a6e5ff839de512e27b731e0fa50c655f2e
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
Citations in the corpus
- 2007 ESH‐ESC Guidelines for the management of arterial hypertension (2007, background): “(299,573) Trials assessing intermediate endpoints (subclinical organ damage) suggest other differences between various antihypertensive agents or compounds: ACE inhibitors and angiotensin receptor antagonists have been reported to be particularly effective in reducing left ventricular hypertrophy, (”
- 2007 Guidelines for the Management of Arterial Hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2007, background): “Because of the limitations of many studies, meta-analyses cannot offer indisputable evidence of advantages of specific drug classes.(349) More reliable information is provided by a number of large and adequately designed studies.”